Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7789]

EHA 2014: Gdf -11 a new target to improve anaemia in thalassemia

EHA 2014: Gdf -11 a new target to improve anaemia in thalassemia

EHA 2014: Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific antibody

EHA 2014: Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific...

EHA 2014: Do generics of imatinib jeopardize patient safety for the sake of saving money? An experience in Turkish patients

EHA 2014: Do generics of imatinib jeopardize patient safety for the sake of saving money? An experience in Turkish...

EHA 2014: Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL

EHA 2014: Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in...

EHA 2014: Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows

EHA 2014: Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows

Ovarian cancer subtypes may predict response to bevacizumab

Ovarian cancer subtypes may predict response to bevacizumab

Advanced breast cancer: benefits of trastuzumab outweigh the risk of harm

Advanced breast cancer: benefits of trastuzumab outweigh the risk of harm

Resurrecting immunity against tumours

Resurrecting immunity against tumours

Researchers discover new form of cancer in the nose

Researchers discover new form of cancer in the nose

Survey sheds light on common clinical practice for incompletely resected lung cancer

Survey sheds light on common clinical practice for incompletely resected lung cancer

More from ecancer